Transdermal fentanyl: a review of its pharmacological properties and therapeutic efficacy in pain control
W Jeal, P Benfield - Drugs, 1997 - Springer
Fentanyl is a synthetic opioid with short-acting analgesic activity after intravenous or
subcutaneous administration. The low molecular weight, high potency and lipid solubility of …
subcutaneous administration. The low molecular weight, high potency and lipid solubility of …
Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl
S Grond, L Radbruch, KA Lehmann - Clinical pharmacokinetics, 2000 - Springer
Transdermal delivery allows continuous systemic application of opioids through the intact
skin. This review analyses the pharmacokinetic properties of transdermal opioid …
skin. This review analyses the pharmacokinetic properties of transdermal opioid …
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often …
J Pergolizzi, RH Böger, K Budd, A Dahan… - Pain …, 2008 - Wiley Online Library
▪ Abstract Summary of consensus: 1. The use of opioids in cancer pain: The criteria for
selecting analgesics for pain treatment in the elderly include, but are not limited to, overall …
selecting analgesics for pain treatment in the elderly include, but are not limited to, overall …
[HTML][HTML] Penetration profile of microspheres in follicular targeting of terminal hair follicles
R Toll, U Jacobi, H Richter, J Lademann… - Journal of Investigative …, 2004 - Elsevier
The transfollicular administration of pharmacologically active molecules is of current
therapeutic interest, mainly with regard to delivery to specific sites of the hair follicle (HF) and …
therapeutic interest, mainly with regard to delivery to specific sites of the hair follicle (HF) and …
Quantitative label-free SERS detection of trace fentanyl in biofluids with a freestanding hydrophobic plasmonic paper biosensor
The prevalence of fentanyl abuse raises global public health concerns with an
unprecedented surge in overdose deaths. Rapid identification and quantification of fentanyl …
unprecedented surge in overdose deaths. Rapid identification and quantification of fentanyl …
Opioid conversions in acute care
AE Patanwala, J Duby, D Waters… - Annals of …, 2007 - journals.sagepub.com
Objective: To discuss the historical basis and limitations of opioid conversion tables, review
the relevant literature, and establish an evidence-based equianalgesic dose ratio (EDR) …
the relevant literature, and establish an evidence-based equianalgesic dose ratio (EDR) …
Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain
B Donner, M Zenz, M Tryba, M Strumpf - Pain, 1996 - Elsevier
Direct conversion from oral morphine to transdermal fentanyl with a ratio of oral
morphine/transdermal fentanyl (100: 1 mg) daily was examined in patients with cancer pain …
morphine/transdermal fentanyl (100: 1 mg) daily was examined in patients with cancer pain …
Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain
CA Kornick, J Santiago-Palma, N Moryl, R Payne… - Drug Safety, 2003 - Springer
Transdermal fentanyl is effective and well tolerated for the treatment of chronic pain caused
by malignancy and non-malignant conditions when administered according to the …
by malignancy and non-malignant conditions when administered according to the …
Pain management in patients with pancreatic carcinoma
A Caraceni, RK Portenoy - … International Journal of the …, 1996 - Wiley Online Library
Pancreatic cancer has a very poor prognosis and is often associated with severe pain. A
variety of pain syndromes and pain pathophysiologies can be identified. Information about …
variety of pain syndromes and pain pathophysiologies can be identified. Information about …
Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management
A Paix, A Coleman, J Lees, J Grigson, M Brooksbank… - PAIN®, 1995 - Elsevier
Eleven patients with cancer pain in a palliative care and chronic pain service required
cessation of morphine due to unacceptable opioid side effects. In this retrospective study …
cessation of morphine due to unacceptable opioid side effects. In this retrospective study …